|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/41 | |
| A61K 31/4178 | |||
| A61K 31/4184 | |||
| A61K 31/454 | |||
| A61P 25/28 | |||
| A61P 43/00 |
| (11) | Patento numeris | 2174666 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08765314.3 |
| Europos patento paraiškos padavimo data | 2008-06-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-04-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-12-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2008/060513 |
| Data | 2008-06-09 |
| (87) | Numeris | WO 2009/001661 |
| Data | 2008-12-31 |
| (30) | Numeris | Data | Šalis |
| 2007165071 | 2007-06-22 | JP |
| (72) |
MORISHITA, Ryuichi, JP
SATO, Naoyuki, JP
TAKEDA, Shuko, JP
|
| (73) |
Daiichi Sankyo Company, Limited,
3-5-1, Nihonbashi Honcho, Chuo-ku Tokyo 103-8426,
JP
Osaka University, 1-1, Yamadaoka, Suita-shi Osaka 565-0871, JP |
| (54) | MEDICINAL AGENT FOR TREATMENT OF AMYLOID BETA-INDUCED CEREBRAL CIRCULATION OR CEREBRAL BLOOD FLOW DISORDERS |
| MEDICINAL AGENT FOR TREATMENT OF AMYLOID BETA-INDUCED CEREBRAL CIRCULATION OR CEREBRAL BLOOD FLOW DISORDERS |